Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
879.16B
Market cap879.16B
Price-Earnings ratio
40.54
Price-Earnings ratio40.54
Dividend yield
0.67%
Dividend yield0.67%
Average volume
2.65M
Average volume2.65M
High today
$932.50
High today$932.50
Low today
$925.45
Low today$925.45
Open price
$979.94
Open price$979.94
Volume
29.13K
Volume29.13K
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

The current Eli Lilly(LLY) stock price is $925.45, with a market capitalization of 879.16B. The stock trades at a price-to-earnings (P/E) ratio of 40.54 and offers a dividend yield of 67.0%.

As of 2026-03-18, Eli Lilly(LLY) stock has fluctuated between $925.45 and $932.50. The current price stands at $925.45, placing the stock 0.0% above today's low and -0.8% off the high.

Eli Lilly(LLY) shares are trading with a volume of 29.13K, against a daily average of 2.65M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

LLY News

Simply Wall St 3h
Eli Lilly Pediatric EBGLYSS Win Offers Counterpoint To Recent Stock Weakness

Eli Lilly (NYSE:LLY) reported positive topline Phase 3 ADorable-1 results for EBGLYSS (lebrikizumab-lbkz) in pediatric patients with moderate to severe atopic d...

Eli Lilly Pediatric EBGLYSS Win Offers Counterpoint To Recent Stock Weakness
Nasdaq 12h
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics

Key Points Eli Lilly is the leader in the U.S. weight loss drug market, with a 60% share. Viking aims to enter this market -- and so far, its clinical trial r...

Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics
Nasdaq 13h
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move

Key Points Hims & Hers' stock is up after ending its lawsuit with Novo Nordisk. The deal shows that industry power lies with the drugmakers. Both Novo Nordis...

Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move

Analyst ratings

80%

of 35 ratings
Buy
80%
Hold
17.1%
Sell
2.9%

More LLY News

Sherwood News 17h
Stocks edge higher as investors shrug off an uptick oil prices

Stocks built on yesterday’s gains in spite of the ongoing conflict in Iran. A rise in oil propelled energy stocks higher. The S&P 500, Nasdaq 100, and Russell...

Stocks edge higher as investors shrug off an uptick oil prices
The Motley Fool 17h
Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure

Artificial intelligence (AI) has been the hottest thing on Wall Street over the past three years. Many believe the technology is here to stay and will make thos...

Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure
MarketWatch 18h
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales

Eli Lilly’s stock was downgraded over concerns about the scale and staying power of the weight-loss-drug market. In a surprising move, Eli Lilly’s stock has be...

Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
Nasdaq 19h
Why Eli Lilly Stock Just Dropped

Key Points HSBC analyst Rajesh Kumar downgraded Lilly stock to reduce this morning. Kumar believes GLP-1 demand, as measured in dollars, could be as little as...

Why Eli Lilly Stock Just Dropped
24/7 Wall St. 20h
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares By David Moadel Published Mar 17, 12:27PM EDT Quick Read Eli Lill...

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares
24/7 Wall St. 20h
Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216 By Joel South Published Mar 17, 12:25PM EDT Quick Read Eli Lilly (LLY) f...

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216
TipRanks 21h
Eli Lilly Stock Gets a Rare Downgrade. HSBC Sees This Problem Ahead

Eli Lilly’s (LLY) share price is down 4% on March 17 after analysts at British bank HSBC (HSBC) gave the stock a rare downgrade. Claim 70% Off TipRanks Premium...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.